NEW YORK (TheStreet) -- Shares of Walgreen Co. (WAG) are declining, down 0.86% to $67.15 in early market trading on Tuesday, after the retail drugstore chain was downgraded to "neutral" from "buy" with a $72 price target by analysts at Mizuho this morning.
Mizuho lowered its rating on Walgreen based on limited EPS upside and sub-par base business organic growth.
Analysts at the firm also cited the company's execution risk with Alliance Boots due to management turnover, international and currency risk, as well as valuation.
Must Read: Warren Buffett's 25 Favorite Stocks
Deerfield, IL-based Walgreen sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy.
Separately, TheStreet Ratings team rates WALGREEN CO as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate WALGREEN CO (WAG) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income."